Ischemia
Fibrin-derived peptide B beta(15-42) studied, myocardial protection noted
Published in Hematology Week, May 2nd, 2005
"In the event of a myocardial infarction, current interventions aim to reopen the occluded vessel to reduce myocardial damage and injury. Although reperfusion is essential for tissue salvage, it can cause further damage and the onset of inflammation," wrote P. Petzelbauer and colleagues, University Hospital of Dusseldorf.
"We show a novel anti-inflammatory effect of a fibrin-derived peptide, B beta(15-42). This peptide competes with the fibrin fragment N-terminal disulfide knot-II (an analog of the fibrin E1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2005-05-02)
More Articles from Hematology Week
- Colon Cancer
Quercetin inhibits beta-catenin/Tcf signaling in colon cancer cells - Contraceptive Microbicide
Contraceptive microbicide nonoxynol-9 has deleterious effects on endometrium - Diet & Nutrition
Elemental diet improves nutritional recovery from diarrhea/malnutrition - Umbilical Cord Blood
CB chromosomal aberrations associated with prenatal exposure to carcinogenic PAH - Acinetobacter Outbreaks
Acinetobacter baumannii nosocomial outbreak strain produces PER-1 ESBL - Acute Myeloid Leukemia
Chemosensitivity index enables prediction of individual chemotherapy responses - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
